Cardinal Health (CAH) – Investment Analysts’ Weekly Ratings Updates

Several analysts have recently updated their ratings and price targets for Cardinal Health (NYSE: CAH):

• 7/9/2026 – Cardinal Health had its price target raised by TD Cowen from $255.00 to $275.00. They now have a “buy” rating on the stock.
• 7/4/2026 – Cardinal Health was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 7/2/2026 – Cardinal Health had its “buy” rating reaffirmed by Citigroup Inc..
• 7/2/2026 – Cardinal Health had its price target raised by Bank of America Corporation from $240.00 to $260.00. They now have a “buy” rating on the stock.
• 6/15/2026 – Cardinal Health was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 6/12/2026 – Cardinal Health was downgraded by Zacks Research from “strong-buy” to “hold”.
• 6/7/2026 – Cardinal Health was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 5/30/2026 – Cardinal Health was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 5/19/2026 – Cardinal Health was downgraded by Weiss Ratings from “buy (b+)” to “buy (b)”.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is 31.50%.

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.